Polypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhage

Jin Sook Yoon, Jonghyun Lee, Sung Chul Lee, Hyoung Jun Koh, Sung Soo Kim, Oh Woong Kwon

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Purpose: To determine and compare the clinical characteristics, visual prognosis and treatment of hemorrhagic polypoidal choroidal vasculopathy (HPCV) with those of hemorrhagic choroidal neovascularization (HCNV) due to age-related macular degeneration (ARMD). Materials and Methods: Retrospective analysis of 44 consecutive eyes with a submacular hemorrhage comprising more than 50% of the neovascular lesion. Patients were diagnosed as having HPCV or HCNV on the basis of indocyanine green angiography. Results: Of the 44 eyes with submacular hemorrhage, 26 were classified as HPCV and 18 as HCNV. The baseline patient characteristics were similar for both groups. At the final follow-up the HPCV group had 17 eyes showing visual improvement, four showing maintained vision, and five showing visual deterioration. In contrast, the HCNV group had four eyes showing visual improvement, one showing maintained vision, and 13 showing visual deterioration. Visual acuity of < 0.1 at follow-up was found in 7 (27 %) of HPCV eyes and 10 (56%) of HCNV eyes. PDT was performed in 15 HPCV eyes, of which 13 (87%) showed improvement or no change in visual acuity, while only 2 (22%) of the 9 HCNV eyes responded similarly after PDT. Eyes treated with PDT did not have better outcomes compared to eyes that underwent other types of treatment (Fisher's exact test, p > 0.05). Conclusion: PCV accounts for the largest proportion of submacular hemorrhage in Koreans. PCV showed a better visual prognosis than CNV.

Original languageEnglish
Pages (from-to)225-232
Number of pages8
JournalYonsei medical journal
Volume48
Issue number2
DOIs
Publication statusPublished - 2007 Apr 1

Fingerprint

Choroidal Neovascularization
Hemorrhage
Indocyanine Green
Macular Degeneration
Visual Acuity
Angiography
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Yoon, Jin Sook ; Lee, Jonghyun ; Lee, Sung Chul ; Koh, Hyoung Jun ; Kim, Sung Soo ; Kwon, Oh Woong. / Polypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhage. In: Yonsei medical journal. 2007 ; Vol. 48, No. 2. pp. 225-232.
@article{9a0a4dc82fd74073aaf97cbc25effcf7,
title = "Polypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhage",
abstract = "Purpose: To determine and compare the clinical characteristics, visual prognosis and treatment of hemorrhagic polypoidal choroidal vasculopathy (HPCV) with those of hemorrhagic choroidal neovascularization (HCNV) due to age-related macular degeneration (ARMD). Materials and Methods: Retrospective analysis of 44 consecutive eyes with a submacular hemorrhage comprising more than 50{\%} of the neovascular lesion. Patients were diagnosed as having HPCV or HCNV on the basis of indocyanine green angiography. Results: Of the 44 eyes with submacular hemorrhage, 26 were classified as HPCV and 18 as HCNV. The baseline patient characteristics were similar for both groups. At the final follow-up the HPCV group had 17 eyes showing visual improvement, four showing maintained vision, and five showing visual deterioration. In contrast, the HCNV group had four eyes showing visual improvement, one showing maintained vision, and 13 showing visual deterioration. Visual acuity of < 0.1 at follow-up was found in 7 (27 {\%}) of HPCV eyes and 10 (56{\%}) of HCNV eyes. PDT was performed in 15 HPCV eyes, of which 13 (87{\%}) showed improvement or no change in visual acuity, while only 2 (22{\%}) of the 9 HCNV eyes responded similarly after PDT. Eyes treated with PDT did not have better outcomes compared to eyes that underwent other types of treatment (Fisher's exact test, p > 0.05). Conclusion: PCV accounts for the largest proportion of submacular hemorrhage in Koreans. PCV showed a better visual prognosis than CNV.",
author = "Yoon, {Jin Sook} and Jonghyun Lee and Lee, {Sung Chul} and Koh, {Hyoung Jun} and Kim, {Sung Soo} and Kwon, {Oh Woong}",
year = "2007",
month = "4",
day = "1",
doi = "10.3349/ymj.2007.48.2.225",
language = "English",
volume = "48",
pages = "225--232",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "2",

}

Polypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhage. / Yoon, Jin Sook; Lee, Jonghyun; Lee, Sung Chul; Koh, Hyoung Jun; Kim, Sung Soo; Kwon, Oh Woong.

In: Yonsei medical journal, Vol. 48, No. 2, 01.04.2007, p. 225-232.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Polypoidal choroidal vasculopathy in Korean patients with large submacular hemorrhage

AU - Yoon, Jin Sook

AU - Lee, Jonghyun

AU - Lee, Sung Chul

AU - Koh, Hyoung Jun

AU - Kim, Sung Soo

AU - Kwon, Oh Woong

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Purpose: To determine and compare the clinical characteristics, visual prognosis and treatment of hemorrhagic polypoidal choroidal vasculopathy (HPCV) with those of hemorrhagic choroidal neovascularization (HCNV) due to age-related macular degeneration (ARMD). Materials and Methods: Retrospective analysis of 44 consecutive eyes with a submacular hemorrhage comprising more than 50% of the neovascular lesion. Patients were diagnosed as having HPCV or HCNV on the basis of indocyanine green angiography. Results: Of the 44 eyes with submacular hemorrhage, 26 were classified as HPCV and 18 as HCNV. The baseline patient characteristics were similar for both groups. At the final follow-up the HPCV group had 17 eyes showing visual improvement, four showing maintained vision, and five showing visual deterioration. In contrast, the HCNV group had four eyes showing visual improvement, one showing maintained vision, and 13 showing visual deterioration. Visual acuity of < 0.1 at follow-up was found in 7 (27 %) of HPCV eyes and 10 (56%) of HCNV eyes. PDT was performed in 15 HPCV eyes, of which 13 (87%) showed improvement or no change in visual acuity, while only 2 (22%) of the 9 HCNV eyes responded similarly after PDT. Eyes treated with PDT did not have better outcomes compared to eyes that underwent other types of treatment (Fisher's exact test, p > 0.05). Conclusion: PCV accounts for the largest proportion of submacular hemorrhage in Koreans. PCV showed a better visual prognosis than CNV.

AB - Purpose: To determine and compare the clinical characteristics, visual prognosis and treatment of hemorrhagic polypoidal choroidal vasculopathy (HPCV) with those of hemorrhagic choroidal neovascularization (HCNV) due to age-related macular degeneration (ARMD). Materials and Methods: Retrospective analysis of 44 consecutive eyes with a submacular hemorrhage comprising more than 50% of the neovascular lesion. Patients were diagnosed as having HPCV or HCNV on the basis of indocyanine green angiography. Results: Of the 44 eyes with submacular hemorrhage, 26 were classified as HPCV and 18 as HCNV. The baseline patient characteristics were similar for both groups. At the final follow-up the HPCV group had 17 eyes showing visual improvement, four showing maintained vision, and five showing visual deterioration. In contrast, the HCNV group had four eyes showing visual improvement, one showing maintained vision, and 13 showing visual deterioration. Visual acuity of < 0.1 at follow-up was found in 7 (27 %) of HPCV eyes and 10 (56%) of HCNV eyes. PDT was performed in 15 HPCV eyes, of which 13 (87%) showed improvement or no change in visual acuity, while only 2 (22%) of the 9 HCNV eyes responded similarly after PDT. Eyes treated with PDT did not have better outcomes compared to eyes that underwent other types of treatment (Fisher's exact test, p > 0.05). Conclusion: PCV accounts for the largest proportion of submacular hemorrhage in Koreans. PCV showed a better visual prognosis than CNV.

UR - http://www.scopus.com/inward/record.url?scp=34248229185&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34248229185&partnerID=8YFLogxK

U2 - 10.3349/ymj.2007.48.2.225

DO - 10.3349/ymj.2007.48.2.225

M3 - Article

C2 - 17461520

AN - SCOPUS:34248229185

VL - 48

SP - 225

EP - 232

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 2

ER -